Controversy on W3 supplements now in Court but about free speech and free marketing

http://www.streetinsider.com/Corporate+News/Amarin+%28AMRN%29+Files+Suit+Against+FDA+Related+to+Off-Label+Promotion/10536594.html

http://www.medpagetoday.com/Cardiology/Prevention/51464?isalert=1&uun=g432148d3992R5529932u&utm_source=breaking-news&utm_medium=email&utm_campaign=breaking-news&xid=NL_breakingnews_2015-05-11